Jan 06 2025
A study published in the journal Addiction by researchers from the University of Granada in Spain shows that vaporized cannabidiol (CBD) has little to no effect on visual function and driving performance. The randomized, double-blind, placebo-controlled crossover experiment assessed whether CBD impacts the ability to drive safely. The study involved 30 participants with an average …
Jan 05 2025
A new study published in the International Journal of Molecular Sciences investigates the potential of Mitragyna speciosa (commonly known as kratom) in addressing Alzheimer’s disease (AD), a neurodegenerative condition with limited treatment options. The research, conducted by teams from Walailak University in Thailand, the University of Kentucky, and the University of Chittagong in Bangladesh, employed …
Jan 03 2025
Researchers from the University of Alberta and Western Canada High School have conducted a study exploring the therapeutic potential of psilocybin in mitigating behavioral despair and cognitive impairments caused by chronic stress. Published in the peer reviewed journal Progress in Neuro-Psychopharmacology and Biological Psychiatry, the research focuses on the interaction between the Hypothalamic-Pituitary-Adrenal (HPA) axis …
Jan 03 2025
A single dose of psilocybin may offer relief for patients with severe treatment-resistant depression, according to an open-label study published in the American Journal of Psychiatry. The research, conducted by teams from Columbia University, Stanford University School of Medicine, and the University of Maryland, aimed to evaluate the safety and efficacy of psilocybin in individuals …
Jan 02 2025
According to the results of a new clinical trial, psilocybin holds promise as a tool for reshaping personality traits in people battling alcohol addiction. Researchers from New York University, the University of New Mexico School of Medicine, NYU Grossman School of Medicine, and Arizona State University conducted a randomized controlled trial to explore the effects …
Jan 01 2025
A study published in the journal Frontiers in Plant Science by researchers from Humboldt-Universität zu Berlin examines how different UV spectra and intensities impact cannabis growth, yield, and secondary metabolite composition. The study tested three UV light spectra at five intensity levels, analyzing their effects on photomorphogenesis, inflorescence yield, and the chemical profile of cannabis. While …
Jan 01 2025
A cost-utility analysis has shown that CBD in combination with usual care offers a cost-effective treatment option for patients with Lennox-Gastaut syndrome (LGS) or Dravet syndrome (DS) in the Netherlands. This study, published in the Journal of Health Economics and Outcomes Research, evaluated the economic and clinical benefits of using plant-derived, highly purified CBD (Epidyolex) …
Dec 31 2024
SciSparc Ltd., a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, has received renewed approval from the Israeli Medical Cannabis Agency to conduct a clinical trial of SCI-210, a CBD and CannAmide combination, for children with autism spectrum disorder (ASD). This renewal reaffirms the Company’s …
Dec 31 2024
A new study suggests cannabidiol (CBD) could be a game-changer in fighting gum disease, showing significant antibacterial and antibiofilm effects against harmful oral bacteria. Researchers from Brazil’s Federal University of São João del Rei and Universidade Federal de Uberlândia found CBD to be both effective and non-toxic, highlighting its potential as a therapeutic option for …
Dec 30 2024
The University of California San Diego (UCSD) is seeking participants for six marijuana-related clinical trials. The university is currently conducting seven clinical trials related to marijuana and its compounds, with all but one currently open to new participants (the seventh is “currently not accepting new patients, but might later”). Below is a breakdown of these …
